Abstract
Objectives DXA scans may offer a novel means of evaluating radiographic knee osteoarthritis (rKOA) in large population studies and through opportunistic screening. We aimed to develop and apply a semi-automated method for assessing rKOA using ∼20,000 knee DXA images from UK Biobank (UKB) and assess its face validity by checking for expected relationships with clinical outcomes.
Methods Right knee DXA scans were manually annotated for osteophytes to derive corresponding grades. Joint space narrowing (JSN) grades in the medial joint compartment were determined from automatically measured minimum joint space width. Overall rKOA grade (0-4) was determined by combining osteophyte and JSN grades. Logistic regression was employed to investigate the associations of osteophyte, JSN, and rKOA grades with knee pain and hospital-diagnosed knee osteoarthritis (HES-KOA). Cox proportional hazards modelling was used to examine the associations of these variables with risk of subsequent total knee replacement (TKR).
Results Of the 19,595 participants included (mean age: 63.7), 19.5% had rKOA grade ≥1 (26.1% female; 12.5% male). Grade ≥1 osteophytes and grade ≥1 JSN were associated with knee pain, HES-KOA, and TKR. Higher rKOA grades were linked to stronger associations with these clinical outcomes, with the most pronounced effects observed for TKR. HRs for the association of rKOA grades with TKR were 3.28, 8.75, and 28.63 for grades 1, 2 and 3-4, respectively.
Conclusions Our DXA-derived measure of rKOA demonstrated a progressive relationship with clinical outcomes. These findings support the use of DXA for classifying rKOA in large epidemiological studies and in future population-based screening.
Key messages
Radiographic knee osteoarthritis (rKOA) can be semi-automatically derived from DXA images.
DXA-derived rKOA shows expected relationships with clinical outcomes of knee osteoarthritis.
DXA imaging presents a viable method for classifying rKOA in large-scale epidemiological research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded in whole, or in part, by the Wellcome Trust [Grant numbers: 209233/Z/17/Z, 223267/Z/21/Z]. BGF is funded by an NIHR Academic Clinical Lectureship. CL is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (223267/Z/21/Z). NCH is supported by grants from Medical Research Council (MRC) [MC_PC_21003; MC_PC_21001] and the NIHR Southampton Biomedical Research Centre.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UKB has full ethical approval from the National Information Governance Board for Health and Social Care and the North-West Multi-Centre Research Ethics Committee (11/NW/0382). All UKB participants provided consent, including permission for their health to be followed-up through linkage to health-related records. This study was approved by UKB under application number 17295.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The data from this study will be available from UK Biobank in an upcoming data release. To access these resources, users must register with UK Biobank at: https://www.ukbiobank.ac.uk/enable-your-research/register. The BoneFinder® knee module and Markup-Tool are freely available on request: https://bone-finder.com/
